Close

Amgen (AMGN) Announces Kyprolis MAA Acceptance by EMA

February 27, 2015 9:05 AM EST Send to a Friend
Amgen (Nasdaq: AMGN) and its subsidiary Onyx Pharmaceuticals, Inc. announced that the European Medicines Agency (EMA) has accepted the Marketing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login